Topic Review
Interaction between AD and Cerebral Small Vessel Disease
Alzheimer’s disease (AD) is characterized by the presence of β-amyloid (Aβ) and tau, and subcortical vascular cognitive impairment (SVCI) is characterized by cerebral small vessel disease (CSVD). They are the most common causes of cognitive impairment in the elderly population. Concurrent CSVD burden is more commonly observed in AD-type dementia than in other neurodegenerative diseases. The developments in Aβ and tau positron emission tomography (PET) have enabled the investigation of the relationship between AD biomarkers and CSVD in vivo.
  • 454
  • 23 Sep 2022
Topic Review
Boron Neutron Capture Therapy
Boron neutron capture therapy (BNCT) is a type of targeted radiotherapy. BNCT shows promising results in treating lung cancer, recurrent head and neck cancer, sarcomas, and high grade brain tumors.
  • 448
  • 29 Nov 2021
Topic Review
Vessel Wall Magnetic Resonance Imaging in Cerebrovascular Diseases
Cerebrovascular diseases are a leading cause of disability and death worldwide. The definition of stroke etiology is mandatory to predict outcome and guide therapeutic decisions. The diagnosis of pathological processes involving intracranial arteries is especially challenging, and the visualization of intracranial arteries’ vessel walls is not possible with routine imaging techniques. Vessel wall magnetic resonance imaging (VW-MRI) uses high-resolution, multiparametric MRI sequences to directly visualize intracranial arteries walls and their pathological alterations, allowing a better characterization of their pathology. VW-MRI demonstrated a wide range of clinical applications in acute cerebrovascular disease. Above all, it can be of great utility in the differential diagnosis of atherosclerotic and non-atherosclerotic intracranial vasculopathies. Additionally, it can be useful in the risk stratification of intracranial atherosclerotic lesions and to assess the risk of rupture of intracranial aneurysms. Recent advances in MRI technology made it more available, but larger studies are still needed to maximize its use in daily clinical practice. 
  • 433
  • 07 Feb 2022
Topic Review
MRI Response Assessment in Glioblastoma Patients Treated
In order to compare responses to different therapies among clinical trials and to differentiate between therapy-induced changes and true tumor progression, reliable response parameters are crucial. MRI scans were evaluated using MacDonald, RANO, Vol-RANO, mRANO, Vol-mRANO and iRANO criteria. Tumor volumes (T1 contrast-enhancing as well as T2/FLAIR volumes) were calculated by semiautomatic segmentation.
  • 421
  • 25 Mar 2022
Topic Review
Functionalized Nanomaterials as Theranostic Agents in Brain Imaging
Theranostic nanoparticles in molecular imaging significantly impact non-invasive strategies to understand biological and biochemical events in intact cells within living subjects. It plays a prominent role in disease diagnosis and therapeutic monitoring outcomes in vivo. The theranostic application of nanomaterials can be classified into morphological and functional imaging based on their roles in image contrast abilities during applicable imaging methods.
  • 393
  • 08 Apr 2022
Topic Review
Neurotransmitter Imaging in Parkinsonian Disorders
Neurodegenerative parkinsonian disorders are characterized by a great diversity of clinical symptoms and underlying neuropathology, yet differential diagnosis during lifetime remains probabilistic. Molecular imaging is a powerful method to detect pathological changes in vivo on a cellular and molecular level with high specificity. Thereby, molecular imaging enables to investigate functional changes and pathological hallmarks in neurodegenerative disorders, thus allowing to better differentiate between different forms of degenerative parkinsonism, improve the accuracy of the clinical diagnosis and disentangle the pathophysiology of disease-related symptoms. 
  • 390
  • 21 Sep 2022
Topic Review
Safety Related Bioeffects of Clinical Ultrasound Neuromodulation
Transcranial ultrasound holds much potential as a safe, non-invasive modality for navigated neuromodulation, with low-intensity focused ultrasound (FUS) and transcranial pulse stimulation (TPS) representing the two main modalities.
  • 389
  • 18 Nov 2022
Topic Review
Glioblastoma Radiomics
Glioblastoma (GBM) is a cancer with poor prognosis, its 5-year survival expectation is approximately 5%. Radiomics is a field of medical imaging analysis that focuses on the extraction of many quantitative imaging features related to shape, intensity and texture. These features are incorporated into models designed to predict important clinical or biological endpoints for patients. Glioblastoma multiforme (GBM) patients stand to benefit from this emerging research field as radiomics has the potential to assess the biological heterogeneity of the tumour, which contributes significantly to the inefficacy of current standard of care therapy.
  • 373
  • 13 Sep 2022
Topic Review
Imaging Biomarkers in Chronic Neuropathic Pain Management
Chronic neuropathic pain is a very important public health issue with profound negative implications in many aspects of patients’ individual lives, as well as society, health systems, productivity, and macroeconomics. The development of imaging, especially molecular and functional imaging, provides objectivity and makes the connection between structural changes, receptors involved in the mechanisms of action, and potentially therapeutic or diagnostic molecules by highlighting the place of action and the involved systems. The approval of composite biomarkers, including serological, genetic, clinical, and imaging markers, with high sensitivity and specificity will accelerate and improve diagnosis, staging, predictive and prognostic evaluation, stratification (phenotyping) and inclusion in trials, and the development of therapeutic options (pharmacological, biomedical) through preclinical, translational, clinical studies. 
  • 370
  • 06 Jan 2023
Topic Review
Magnetic Resonance Imaging Assessment in Brain Tumor
The non-enhancing peritumoral area (NEPA) is defined as the hyperintense region in T2-weighted and fluid-attenuated inversion recovery (FLAIR) images surrounding a brain tumor. The NEPA corresponds to different pathological processes, including vasogenic edema and infiltrative edema. The analysis of the NEPA with conventional and advanced magnetic resonance imaging (MRI) was proposed in the differential diagnosis of solid brain tumors, showing higher accuracy than MRI evaluation of the enhancing part of the tumor. In particular, MRI assessment of the NEPA was demonstrated to be a promising tool for distinguishing high-grade gliomas from primary lymphoma and brain metastases. Additionally, the MRI characteristics of the NEPA were found to correlate with prognosis and treatment response.
  • 357
  • 16 Jun 2023
  • Page
  • of
  • 5